1025961-08-3

Basic information

• Product Name: 8-Phenyl-4-trifluoromethanesulfonyloxy-naphthalene-2-carboxylic acid methyl ester
• Synonyms: 8-Phenyl-4-trifluoromethanesulfonyloxy-naphthalene-2-carboxylic acid methyl ester
• CAS NO: 1025961-08-3
• Molecular Weight: 410.37
• Mol File: 1025961-08-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 8-Phenyl-4-trifluoromethanesulfonyloxy-naphthalene-2-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Phenyl-4-trifluoromethanesulfonyloxy-naphthalene-2-carboxylic acid methyl ester(1025961-08-3)
• EPA Substance Registry System: 8-Phenyl-4-trifluoromethanesulfonyloxy-naphthalene-2-carboxylic acid methyl ester(1025961-08-3)

Safety Data

• Hazardous Substances Data: 1025961-08-3(Hazardous Substances Data)

Upstream product

• 181258-97-9 4-Acetoxy-8-trifluoromethanesulfonyloxy-naphthalene-2-carboxylic acid methyl ester 
• 181258-95-7 4-Acetoxy-8-phenyl-naphthalene-2-carboxylic acid methyl ester 
• 181258-96-8 4-Acetoxy-8-hydroxy-naphthalene-2-carboxylic acid methyl ester 
• 144003-45-2 methyl 4-acetoxy-8-(phenylmethoxy)-2-naphthalenecarboxylate 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 181258-99-1 4-Hydroxy-8-phenyl-naphthalene-2-carboxylic acid methyl ester 

Downstream Products

• 181259-04-1 4-(2-Hydroxy-ethyl)-8-phenyl-naphthalene-2-carboxylic acid methyl ester 
• 181259-06-3 4-Carboxymethyl-8-phenyl-naphthalene-2-carboxylic acid methyl ester 
• 181259-08-5 4-[(Methyl-phenethyl-carbamoyl)-methyl]-8-phenyl-naphthalene-2-carboxylic acid methyl ester 
• 181259-02-9 8-Phenyl-4-vinyl-naphthalene-2-carboxylic acid methyl ester 

Relevant articles and documents

Structure-activity relationships study of two series of leukotriene B4 antagonists: Novel indolyl and naphthyl compounds substituted with a 2- [methyl(2-phenethyl)amino]-2-oxoethyl side chain

N-Methyl-N-phenethylphenylacetamide has been reported to be a key binding domain to LTB4 receptors. Here we describe the synthesis and structure-activity relationship (SAR) studies of two new series of LTB4 receptor antagonists in wh